| Followers | 500 |
| Posts | 10140 |
| Boards Moderated | 0 |
| Alias Born | 04/28/2014 |
Saturday, June 13, 2015 10:17:58 PM
bullish
## source: finance.yahoo.com
Mon, 08 Jun 2015 13:17:02 GMT ~ Ultragenyx Announces Completion of Enrollment in Phase 3 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis Type 7
[at noodls] - NOVATO, Calif., June 8, 2015 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, ...
read full: http://www.noodls.com/view/6C3658995B817A651D2EC2AE11B355A918994EF6
*********************************************************
Mon, 08 Jun 2015 13:00:00 GMT ~ Ultragenyx Announces Completion of Enrollment in Phase 3 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis Type 7
[GlobeNewswire] - NOVATO, Calif. -- Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced it has completed patient enrollment ...
read full: http://finance.yahoo.com/news/ultragenyx-announces-completion-enrollment-phase-130000501.html
*********************************************************
Thu, 04 Jun 2015 13:31:11 GMT ~ Ultragenyx Appoints Dennis Huang as Chief Technical Operations Officer and Senior Vice President
[at noodls] - NOVATO, Calif., June 4, 2015 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, ...
read full: http://www.noodls.com/view/F3860C2675B8ADEE791EB0BC3C0FE3CA94026752
*********************************************************
Thu, 04 Jun 2015 13:00:00 GMT ~ Ultragenyx Appoints Dennis Huang as Chief Technical Operations Officer and Senior Vice President
[GlobeNewswire] - NOVATO, Calif. -- Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced it has appointed Dennis Huang ...
read full: http://finance.yahoo.com/news/ultragenyx-appoints-dennis-huang-chief-130000146.html
*********************************************************
Wed, 03 Jun 2015 19:00:07 GMT ~ Ultragenyx KRN23 Positive in Children, to be Studied in Adults - Analyst Blog
read full: http://finance.yahoo.com/news/ultragenyx-krn23-positive-children-studied-190007809.html
*********************************************************
$RARE charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$RARE company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RARE/company-info
Ticker: $RARE
OTC Market Place: Not Available
CIK code: not found
Company name: Ultragenyx Pharmaceutical Inc.
Incorporated In:
$RARE share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$RARE extra dd links
Company name: Ultragenyx Pharmaceutical Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RARE/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RARE/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RARE+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RARE+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RARE+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RARE/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/news - http://finance.yahoo.com/q/h?s=RARE+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RARE/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RARE/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RARE/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RARE/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RARE/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RARE/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RARE/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RARE+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RARE
DTCC (dtcc.com): http://search2.dtcc.com/?q=Ultragenyx+Pharmaceutical+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Ultragenyx+Pharmaceutical+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Ultragenyx+Pharmaceutical+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RARE/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RARE
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RARE/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RARE/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RARE/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RARE/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RARE/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RARE&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RARE
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RARE+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RARE+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RARE
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RARE
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RARE+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RARE/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RARE+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RARE.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RARE
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RARE/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RARE/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RARE/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RARE/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RARE
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RARE
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RARE:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RARE
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RARE
$RARE DD Notes ~ http://www.ddnotesmaker.com/RARE
Recent RARE News
- Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE • PR Newswire (US) • 03/30/2026 07:41:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/27/2026 08:31:20 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/27/2026 08:30:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/27/2026 08:30:23 PM
- RARE Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Ultragenyx Pharmaceutical Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/24/2026 01:00:00 PM
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/20/2026 08:30:00 PM
- RARE Shareholder Alert: Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm • PR Newswire (US) • 03/17/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:45:25 PM
- Ultragenyx Announces Positive 36-Week Data from Phase 3 Study of DTX301 AAV8 Gene Therapy for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency • GlobeNewswire Inc. • 03/12/2026 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/10/2026 08:42:28 PM
- Investors who lost money on Ultragenyx Pharmaceutical Inc.(RARE) should contact The Gross Law Firm about pending Class Action - RARE • PR Newswire (US) • 03/10/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2026 10:28:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 12:09:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 12:08:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:51:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:51:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:50:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:49:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:49:10 PM
- Shareholders that lost money on Ultragenyx Pharmaceutical Inc.(RARE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 10:08:35 PM
- Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE • PR Newswire (US) • 03/02/2026 08:50:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Ultragenyx Pharmaceutical Inc.(RARE) Shareholders • PR Newswire (US) • 02/24/2026 02:00:00 PM
- Ultragenyx to Participate at Investor Conferences in March • GlobeNewswire Inc. • 02/23/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 01:45:26 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM

